-
公开(公告)号：US09592248B2
公开(公告)日：2017-03-14
申请号：US14860233
申请日：2015-09-21
Applicant: Ritter Pharmaceuticals, Inc.
Inventor： Andrew J. Ritter , Dennis Savaiano , David Barnes , Todd Klaenhammer
IPC: C12P19/04 , A61K31/702 , A61K31/715 , A61K35/742 , A61K35/744 , A61K9/48
CPC classification number: A61K31/702 , A23L33/10 , A23L33/135 , A23L33/21 , A23V2002/00 , A61K9/4825 , A61K9/4891 , A61K31/715 , A61K35/742 , A61K35/744 , Y02A50/473 , A61K2300/00 , A23V2200/3202 , A23V2250/28
Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.
Abstract translation: 本发明提供了用于治疗与乳糖不耐症有关的症状和胃肠健康的总体改善的方法和药物组合物。 本文描述的是通过向有需要的受试者施用包含益生元的药物组合物，任选地与有效量的益生菌微生物或微生物组合，来改善整体胃肠健康或降低乳糖不耐症的症状的方法和药物组合物。
-
公开(公告)号：US09579340B2
公开(公告)日：2017-02-28
申请号：US14846449
申请日：2015-09-04
Applicant: Ritter Pharmaceuticals, Inc.
Inventor： Andrew J. Ritter , Dennis Savaiano , David Barnes , Todd Klaenhammer
IPC: C12P19/04 , A61K31/715 , A61K31/702 , A61K35/745 , A61K35/747 , A61K31/7016 , A61K35/741 , A61K9/48
CPC classification number: A61K31/715 , A23L33/135 , A23L33/21 , A23V2002/00 , A23Y2220/00 , A23Y2300/00 , A61K9/4825 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K35/741 , A61K35/745 , A61K35/747 , Y02A50/473 , A61K2300/00 , A23V2200/32 , A23V2200/3202 , A23V2200/3204
Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.
Abstract translation: 本发明提供了用于治疗与乳糖不耐症有关的症状以及胃肠健康的总体改善的方法和组合物。 本文描述的是通过向有需要的受试者施用益生元组合物，任选地与有效量的益生菌微生物或微生物组合，来改善整体胃肠健康或降低乳糖不耐症的症状的方法和组合物。
-
公开(公告)号：US20150133398A1
公开(公告)日：2015-05-14
申请号：US14485301
申请日：2014-09-12
Applicant: RITTER PHARMACEUTICALS, INC.
Inventor： Andrew J. Ritter , Dennis Savaiano , David Barnes , Todd Klaenhammer
IPC: A61K31/702 , A61K31/7016
CPC classification number: A61K31/715 , A23L33/135 , A23L33/21 , A23V2002/00 , A23Y2220/00 , A23Y2300/00 , A61K9/4825 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K35/741 , A61K35/745 , A61K35/747 , Y02A50/473 , A61K2300/00 , A23V2200/32 , A23V2200/3202 , A23V2200/3204
Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.
Abstract translation: 本发明提供了用于治疗与乳糖不耐症有关的症状以及胃肠健康的总体改善的方法和组合物。 本文描述的是通过向有需要的受试者施用益生元组合物，任选地与有效量的益生菌微生物或微生物组合，来改善整体胃肠健康或降低乳糖不耐症的症状的方法和组合物。
-
公开(公告)号：US20170216328A1
公开(公告)日：2017-08-03
申请号：US15301702
申请日：2015-04-02
Applicant: Ritter Pharmaceuticals, Inc.
Inventor： Andrew Justin Ritter , Dennis Savaiano , Todd Klaenhammer
IPC: A61K31/702 , A23L33/21 , C12Q1/68 , A23L33/125 , A61K47/26 , A61K47/12
CPC classification number: A61K31/702 , A23L33/125 , A23L33/21 , A23V2002/00 , A61K9/2022 , A61K31/7004 , A61K31/7016 , A61K45/06 , A61K47/12 , A61K47/26 , C12Q1/689 , C12Q2600/106 , C12Q2600/158 , A61K2300/00
Abstract: A method to improve gastrointestinal health by colonic microbiome alteration, the method comprising administering to a subject in need thereof an effective amount of a composition comprising one or more indigestible oligosaccharides and less than about 20% digestible saccharides by weight, wherein an abundance of one or more beneficial bacteria in the subject's colonic micro-biome is increased after administration of the composition.
-
公开(公告)号：US20180250324A1
公开(公告)日：2018-09-06
申请号：US15710716
申请日：2017-09-20
Applicant: Ritter Pharmaceuticals, Inc.
Inventor： Andrew J. Ritter , Dennis Savaiano , David Barnes , Todd Klaenhammer
IPC: A61K31/715 , A61K31/7004 , A61K31/7016 , A23L33/21 , A61K9/48 , A61K35/741 , A23L33/135 , A61K31/702 , A61K35/745 , A61K35/747
CPC classification number: A61K31/715 , A23L33/135 , A23L33/21 , A23V2002/00 , A23Y2220/00 , A23Y2300/00 , A61K9/4825 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K35/741 , A61K35/745 , A61K35/747 , Y02A50/473 , A61K2300/00 , A23V2200/32 , A23V2200/3202 , A23V2200/3204
Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.
-
Patent Agency Ranking
公开(公告)号：US09808481B2
公开(公告)日：2017-11-07
申请号：US15187576
申请日：2016-06-20
Applicant: Ritter Pharmaceuticals, Inc.
Inventor： Andrew J. Ritter , Dennis Savaiano , David Barnes , Todd Klaenhammer
IPC: A61K31/702 , A61K31/715 , A61K35/745 , A61K35/747 , A61K31/7016 , A61K35/741 , A61K9/48 , A23L33/21 , A23L33/135 , A61K31/7004
CPC classification number: A61K31/715 , A23L33/135 , A23L33/21 , A23V2002/00 , A23Y2220/00 , A23Y2300/00 , A61K9/4825 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K35/741 , A61K35/745 , A61K35/747 , Y02A50/473 , A61K2300/00 , A23V2200/32 , A23V2200/3202 , A23V2200/3204
Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.
-
公开(公告)号：US09775860B2
公开(公告)日：2017-10-03
申请号：US14849424
申请日：2015-09-09
Applicant: Ritter Pharmaceuticals, Inc.
Inventor： Andrew J. Ritter , Dennis Savaiano , David Barnes , Todd Klaenhammer
IPC: C12P19/04 , A61K35/20 , C12P1/04 , A61K31/715 , A61K31/702 , A61K35/745 , A61K35/747 , A61K31/7016 , A61K35/741 , A61K9/48 , A23L33/21 , A23L33/135 , A61K31/7004
CPC classification number: A61K31/715 , A23L33/135 , A23L33/21 , A23V2002/00 , A23Y2220/00 , A23Y2300/00 , A61K9/4825 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K35/741 , A61K35/745 , A61K35/747 , Y02A50/473 , A61K2300/00 , A23V2200/32 , A23V2200/3202 , A23V2200/3204
Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.
-
公开(公告)号：US09370532B2
公开(公告)日：2016-06-21
申请号：US14485301
申请日：2014-09-12
Applicant: RITTER PHARMACEUTICALS, INC.
Inventor： Andrew J. Ritter , Dennis Savaiano , David Barnes , Todd Klaenhammer
IPC: C12P19/04 , A61K35/20 , C12P1/04 , A61K31/715 , A23L1/308 , A61K31/702 , A61K35/745 , A61K35/747 , A61K31/7016 , A61K35/741 , A61K9/48
CPC classification number: A61K31/715 , A23L33/135 , A23L33/21 , A23V2002/00 , A23Y2220/00 , A23Y2300/00 , A61K9/4825 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K35/741 , A61K35/745 , A61K35/747 , Y02A50/473 , A61K2300/00 , A23V2200/32 , A23V2200/3202 , A23V2200/3204
Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.
-
公开(公告)号：US20150118297A1
公开(公告)日：2015-04-30
申请号：US14293784
申请日：2014-06-02
Applicant: RITTER PHARMACEUTICALS, INC.
Inventor： Andrew J. Ritter , Dennis Savaiano , David Barnes , Todd Klaenhammer
IPC: A61K31/715 , A61K9/48 , A23L1/30
CPC classification number: A61K31/702 , A23L33/10 , A23L33/135 , A23L33/21 , A23V2002/00 , A61K9/4825 , A61K9/4891 , A61K31/715 , A61K35/742 , A61K35/744 , Y02A50/473 , A61K2300/00 , A23V2200/3202 , A23V2250/28
Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.
Abstract translation: 本发明提供了用于治疗与乳糖不耐症有关的症状和胃肠健康的总体改善的方法和药物组合物。 本文描述的是通过向有需要的受试者施用包含益生元的药物组合物，任选地与有效量的益生菌微生物或微生物组合，来改善整体胃肠健康或降低乳糖不耐症的症状的方法和药物组合物。
-
公开(公告)号：US20160367579A1
公开(公告)日：2016-12-22
申请号：US15187576
申请日：2016-06-20
Applicant: Ritter Pharmaceuticals, Inc.
Inventor： Andrew J. Ritter , Dennis Savaiano , David Barnes , Todd Klaenhammer
IPC: A61K31/7004 , A23L33/135 , A23L33/21 , A61K31/702 , A61K31/7016
CPC classification number: A61K31/715 , A23L33/135 , A23L33/21 , A23V2002/00 , A23Y2220/00 , A23Y2300/00 , A61K9/4825 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K35/741 , A61K35/745 , A61K35/747 , Y02A50/473 , A61K2300/00 , A23V2200/32 , A23V2200/3202 , A23V2200/3204
Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.
-
-
-
-
-
-
-
-
-
Search Results
14
records
(took 0.18 seconds)
